InterPharma Pty Ltd, a wholly owned subsidiary of EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, manufacture, and commercialisation of medications in many therapeutic areas. InterPharma partner with leading multinational companies to bring innovative healthcare options to the region. Our extensive network of local and over-seas partners ensures efficient distribution, regulatory compliance, and exceptional medical affairs support.
Our experienced team is passionate about providing high-quality pharmaceutical medicines and services to clinicians and patients. We are committed to fostering strong relationships and ensuring you have access to the medications and support you need.
For more information, visit our website to learn more about our comprehensive healthcare solutions.
Interactions with this LinkedIn account must comply with our privacy policy: https://bit.ly/4dt4WYc
Company Details
- Employees
- 11
- Address
- 39 East Esp, Suite 103,australia
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.interpharma.com.au
- HQ
- Manly, New South Wales
Interpharma Pty Ltd Questions
Interpharma Pty Ltd's website is http://www.interpharma.com.au
Interpharma Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/interpharmaanz
Interpharma Pty Ltd has
11 employees.
View email and phone details for 11
employees at Interpharma Pty Ltd.
Interpharma Pty Ltd's industry is
Pharmaceutical Manufacturing
Interpharma Pty Ltd's top competitors are
The Heart Group,
Auckland Heart Group,
Theravia,
Fresenius Kabi Australia And New Zealand,
Demo Pharmaceuticals S.a.,
Interpharma,
Medtas Pty Ltd,
Blackmores Group,
Bristol Myers Squibb,
3p - Pharmaceutical Pipeline Products App.
Interpharma Pty Ltd's categories are Pharmaceutical Manufacturing
